miR-184 could significantly attenuate metastasis of SCLC through participating in β-catenin signaling and downregulating the endothelial PAS domain protein 1 (EPAS1), which is a transcription factor functioning in various tumors including SCLC [100]. This evidence concerns the gene EPAS1 and small cell lung carcinoma.